Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma

Respiratory Research | Sep 04, 2020 Lung/Thoracic Oncology

Development and validation of an individualized nomogram for predicting overall survival in patients with typical lung carcinoid tumors

American Journal of Clinical Oncology | Sep 04, 2020 Lung/Thoracic Oncology

Population-based treatment patterns and outcomes for stage III non–small cell lung cancer patients: A real-world evidence study

American Journal of Clinical Oncology | Sep 04, 2020 Lung/Thoracic Oncology

Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany

Lung Cancer | Sep 03, 2020 Lung/Thoracic Oncology

Antiseizure drugs and risk of developing smoking‐related chronic obstructive pulmonary disease or lung cancer: A population‐based case–control study

British Journal of Clinical Pharmacology | Sep 03, 2020 Lung/Thoracic Oncology

Metabolic syndrome and risk of lung cancer: An analysis of Korean National Health Insurance Corporation database

Journal of Clinical Endocrinology and Metabolism | Sep 02, 2020 Lung/Thoracic Oncology

Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)

European Journal of Cancer | Sep 02, 2020 Lung/Thoracic Oncology

Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non‐small cell lung cancer after stereotactic body radiation therapy

Cancer Medicine | Aug 31, 2020 Lung/Thoracic Oncology

Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes

Supportive Care in Cancer | Aug 28, 2020 Lung/Thoracic Oncology

Diagnostic accuracy of procalcitonin, neutrophil-to-lymphocyte ratio, and C-reactive protein in detection of bacterial infections and prediction of outcome in nonneutropenic febrile patients with lung malignancy

Journal of Oncology | Aug 28, 2020 Lung/Thoracic Oncology

« Prev 1 … 44 45 46 47 48 … 149 Next »

AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma

Development and validation of an individualized nomogram for predicting overall survival in patients with typical lung carcinoid tumors

Population-based treatment patterns and outcomes for stage III non–small cell lung cancer patients: A real-world evidence study

Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany

Antiseizure drugs and risk of developing smoking‐related chronic obstructive pulmonary disease or lung cancer: A population‐based case–control study

Metabolic syndrome and risk of lung cancer: An analysis of Korean National Health Insurance Corporation database

Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)

Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non‐small cell lung cancer after stereotactic body radiation therapy

Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes

Diagnostic accuracy of procalcitonin, neutrophil-to-lymphocyte ratio, and C-reactive protein in detection of bacterial infections and prediction of outcome in nonneutropenic febrile patients with lung malignancy

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma

Development and validation of an individualized nomogram for predicting overall survival in patients with typical lung carcinoid tumors

Population-based treatment patterns and outcomes for stage III non–small cell lung cancer patients: A real-world evidence study

Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany

Antiseizure drugs and risk of developing smoking‐related chronic obstructive pulmonary disease or lung cancer: A population‐based case–control study

Metabolic syndrome and risk of lung cancer: An analysis of Korean National Health Insurance Corporation database

Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)

Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non‐small cell lung cancer after stereotactic body radiation therapy

Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes

Diagnostic accuracy of procalcitonin, neutrophil-to-lymphocyte ratio, and C-reactive protein in detection of bacterial infections and prediction of outcome in nonneutropenic febrile patients with lung malignancy

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic